Revolution Medicines (RVMD) Current Assets (2019 - 2026)

Revolution Medicines has reported Current Assets for 8 years, with the latest figure at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 7.81% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 7.81% YoY), and the FY2025 full-year result was $2.1 billion, down 10.85% from the prior year.
• Current Assets for Q1 2026 stood at $2.0 billion, down from $2.1 billion in the prior quarter.
• The five-year high for Current Assets was $2.3 billion in Q4 2024, with the low at $483.0 million in Q2 2022.
• Average Current Assets over 5 years is $1.4 billion, with a median of $1.6 billion recorded in 2024.
• Year-over-year, Current Assets retreated 26.92% in 2022 and soared 184.66% in 2023.
• Tracing RVMD's Current Assets over 5 years: stood at $660.2 million in 2022, then soared by 184.66% to $1.9 billion in 2023, then climbed by 23.86% to $2.3 billion in 2024, then fell by 10.85% to $2.1 billion in 2025, then decreased by 5.16% to $2.0 billion in 2026.
• The last three Current Assets figures came in at $2.0 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.

Peer Comparison